<DOC>
	<DOC>NCT01608789</DOC>
	<brief_summary>This study is a prospective, single arm, non-randomized, multi-center clinical study that will be conducted in Europe. It is designed to assess efficacy and safety of the Virtue® Male Sling in post-prostatectomy urinary incontinence.</brief_summary>
	<brief_title>Virtue® European Study</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence, Stress</mesh_term>
	<criteria>The subject has an estimated life expectancy of more than 5 years The subject has confirmed stress urinary incontinence (SUI) through medical history, urodynamics, and/or physical exam for at least 6 months The subject has intrinsic sphincter deficiency due to radical prostatectomy completed at least 1 year prior to implantation date The subject has a good bladder function The subject has failed noninvasive therapies, eg. Pelvic Floor/Kegel exercises, behavioral modification, or biofeedback, for at least 6 months The subject is willing to have the Virtue® Male Sling implanted The subject is able and willing to complete all followup visits and procedures indicated in this protocol The subject is unable or unwilling to comply with all followup requirements according to the study protocol The subject has an active urinary tract infection or active skin infection in region of surgery (temporary exclusion) The subject has compromised immune systems or any other conditions that affect healing The subject has serious bleeding disorders The subject has an urinary incontinence that is not mainly a stress urinary incontinence The subject has a stress urinary incontinence due to TransUrethral Resection or laser surgery of the Prostate (TURP) The subject has incontinence due to neurogenic causes defined as multiple sclerosis, spinal cord/brain injury, CVA, detrusorexternal sphincter dyssynergia, Parkinson's disease, or similar conditions The subject had a previous implant (male sling, Artificial Urinary Sphincter) to treat stress urinary incontinence (previous implanted bulking agents are allowed) The subject has undergone radiation, cryosurgery, or brachy therapy to treat prostate or other pelvic cancer within 6 months The subject is likely to undergo radiation therapy within the next 3 months The subject has a postvoid residual (PVR) &gt; or = 150mL The subject has recently required transurethral instrumentation for urethral or urethrovesical anatomosis stricture within the previous 6 months The subject is enrolled in a concurrent clinical study of any treatment (drug or device) that could affect continence function without the sponsors' approval The subject is deemed unfit for male sling implantation or participation in a research protocol as determined by the attending physician</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Male sling</keyword>
	<keyword>Stress Urinary Incontinence</keyword>
	<keyword>Urination Disorders</keyword>
	<keyword>Urologic Diseases</keyword>
</DOC>